DUBLIN–(BUSINESS WIRE)–The “Global advances in omics technologies enable future drug discovery and growth opportunities” report has been added to from ResearchAndMarkets.com offer.

For a long time, drug discovery followed the same path and used conventional analytical methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development.

Personalized therapy is on the rise and promises to be more effective and efficient in meeting challenges. With a growing interest in personalized and precision medicine, drug development is an area of ​​focus for pharmaceutical players, regulators and everyday people. The existing scenario of one drug for one disease and all patient populations in the category is no longer suitable.

The integration of the latest science and technology will enhance knowledge from traditional drug discovery and take pharmaceutical discovery to the next level. Omics provides granular information that was nearly impossible to obtain and understand in the past, offering data on gene expression, patient cohort, and predictive drug response for proposed drugs. Developments in omics and AI also enable the visualization of disease-drug models.

Omics allows researchers to study different parameters and combine information obtained from genomics, proteomics and metabolomics, which guide drug development decisions. Other types of omics technologies such as glycomics and lipidomics are growing, deepening researchers’ understanding of complex and interconnected biological pathways.

Main topics covered:

1.0 Strategic Imperatives

2.0 Growth Environment Analysis

2.1 Research Context

2.2 Findings

2.3 Omics technologies help researchers understand diseases and develop therapies

2.4 Genomics is one of the most widely used omics technologies

2.5 Glycomics and lipidomics attract stakeholder interest

2.6 Trends driving the landscape of omics in drug discovery

3.0 Need for omics technologies in drug discovery

3.1 Omics technologies can reduce drug discovery times

3.2 Biological data drives drug discovery

3.3 Role of omics in drug discovery

3.4 The benefits of omics-based drug discovery

3.5 Challenges in implementing omics-based approaches

4.0 Technology Analysis

4.1 Genomics is Driving Changes in the Drug Discovery Landscape

4.2 The role of genomic data in the future of drug discovery

4.3 Companies working on genomic data for drug discovery

4.4 Transcriptomics provides information on RNA interactions for drug discovery

4.5 The potential of transcriptomic data in drug discovery

4.6 Companies Providing Transcriptomic Data Analysis Platforms to Perform Sophisticated Drug Discovery Pipeline

4.7 Proteomics will improve current understanding of drug responses

4.8 The potential of proteomics data in drug discovery

4.9 Companies working on proteome analysis for drug discovery

4.10 Metabolomics helps by providing real-time information on biological pathways for drug discovery

4.11 The potential of metabolomics data in drug discovery

4.12 Metabolomics companies

4.13 Glycomics has potential in cancer screening and therapies

4.14 The potential of glycomics data in drug discovery

4.15 Lipidomics help identify biomarkers

4.16 The potential of lipidomics data in drug discovery

4.17 Lipidomics companies

4.18 Multi-omics enables faster validation and testing of targets

4.19 The potential of multi-omics data in drug discovery

5.0 Technology Factors Influencing Adoption of Omics Platform

5.1 Microfluidics and bioinformatics are key to understanding multi-omics data

5.2 AI enables accurate and efficient analysis of dataset patterns

5.3 Key Players Enabling Omics Data Interpretation Using AI and Bioinformatics

5.4 Stakeholders facilitating the interpretation of multi-omics data using AI and bioinformatics

6.0 Omics platforms enabling precision medicine

6.1 Single cell analysis

6.2 Omics platforms facilitate precision medicine

6.3 Omics platforms influence precision medicine outcomes

7.0 Omics Technologies – Overview of Intellectual Property Analysis and Stakeholder Activities

7.1 The patent landscape for omics technologies

7.2 Patent Trends of Various Omics Technologies

7.3 Investments and fundraising attract attention

7.4 Ongoing collaborations in multi-omics data analysis for product development

8.0 Universe of growth opportunities

8.1 Growth Opportunity 1: Build an Omics data center for precision medicine

8.2 Growth Opportunity 2: Reshaping Drug Discovery with the Adoption of Omics Data

8.3 Growth Opportunity 3: Advances in High-Throughput Single-Cell Multi-Omic Platforms

9.0 Appendices

10.0 Key contacts

11.0 Next Steps

For more information on this report, visit https://www.researchandmarkets.com/r/few8ic?